Cargando…
Thioredoxin reductase 1 regulates hepatic inflammation and macrophage activation during acute cholestatic liver injury
Cholestatic liver diseases, including primary sclerosing cholangitis, are characterized by periportal inflammation with progression to hepatic fibrosis and ultimately cirrhosis. We recently reported that the thioredoxin antioxidant response is dysregulated during primary sclerosing cholangitis. The...
Autores principales: | Shearn, Colin T., Anderson, Aimee L., Miller, Colin G., Noyd, Reed C., Devereaux, Michael W., Balasubramaniyan, Nata, Orlicky, David J., Schmidt, Edward E., Sokol, Ronald J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833450/ https://www.ncbi.nlm.nih.gov/pubmed/36633484 http://dx.doi.org/10.1097/HC9.0000000000000020 |
Ejemplares similares
-
The autophagic protein p62 is a target of reactive aldehydes in human and murine cholestatic liver disease
por: Shearn, Colin T., et al.
Publicado: (2022) -
Hepatocyte Hyperproliferation upon Liver-Specific Co-disruption of Thioredoxin-1, Thioredoxin Reductase-1, and Glutathione Reductase
por: Prigge, Justin R., et al.
Publicado: (2017) -
Expression of circadian regulatory genes is dysregulated by increased cytokine production in mice subjected to concomitant intestinal injury and parenteral nutrition
por: Shearn, Colin T., et al.
Publicado: (2023) -
Up‐regulation of miR‐let7a‐5p Leads to Decreased Expression of ABCC2 in Obstructive Cholestasis
por: Balasubramaniyan, Natarajan, et al.
Publicado: (2019) -
miR-199a-5p inhibits the expression of ABCB11 in obstructive cholestasis
por: Balasubramaniyan, Natarajan, et al.
Publicado: (2021)